COLL
Price
$33.00
Change
+$0.64 (+1.98%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
1.24B
21 days until earnings call
DVAX
Price
$10.89
Change
+$0.08 (+0.74%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
1.62B
21 days until earnings call
Interact to see
Advertisement

COLL vs DVAX

Header iconCOLL vs DVAX Comparison
Open Charts COLL vs DVAXBanner chart's image
Collegium Pharmaceutical
Price$33.00
Change+$0.64 (+1.98%)
Volume$4.82K
Capitalization1.24B
Dynavax Technologies
Price$10.89
Change+$0.08 (+0.74%)
Volume$38.22K
Capitalization1.62B
COLL vs DVAX Comparison Chart in %
Loading...
COLL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COLL vs. DVAX commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COLL is a Buy and DVAX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (COLL: $32.36 vs. DVAX: $10.81)
Brand notoriety: COLL and DVAX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: COLL: 147% vs. DVAX: 108%
Market capitalization -- COLL: $1.24B vs. DVAX: $1.62B
COLL [@Pharmaceuticals: Other] is valued at $1.24B. DVAX’s [@Pharmaceuticals: Other] market capitalization is $1.62B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COLL’s FA Score shows that 1 FA rating(s) are green whileDVAX’s FA Score has 0 green FA rating(s).

  • COLL’s FA Score: 1 green, 4 red.
  • DVAX’s FA Score: 0 green, 5 red.
According to our system of comparison, COLL is a better buy in the long-term than DVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COLL’s TA Score shows that 4 TA indicator(s) are bullish while DVAX’s TA Score has 5 bullish TA indicator(s).

  • COLL’s TA Score: 4 bullish, 4 bearish.
  • DVAX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, DVAX is a better buy in the short-term than COLL.

Price Growth

COLL (@Pharmaceuticals: Other) experienced а +6.06% price change this week, while DVAX (@Pharmaceuticals: Other) price change was +6.40% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +55.51%. For the same industry, the average monthly price growth was +85.18%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

COLL is expected to report earnings on Nov 06, 2025.

DVAX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+55.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DVAX($1.62B) has a higher market cap than COLL($1.24B). DVAX (31.63) and COLL (30.17) have similar P/E ratio . COLL YTD gains are higher at: 12.949 vs. DVAX (-15.348). COLL has higher annual earnings (EBITDA): 308M vs. DVAX (9.67M). DVAX has more cash in the bank: 742M vs. COLL (311M). DVAX has less debt than COLL: DVAX (257M) vs COLL (674M). COLL has higher revenues than DVAX: COLL (567M) vs DVAX (232M).
COLLDVAXCOLL / DVAX
Capitalization1.24B1.62B77%
EBITDA308M9.67M3,186%
Gain YTD12.949-15.348-84%
P/E Ratio30.1731.6395%
Revenue567M232M244%
Total Cash311M742M42%
Total Debt674M257M262%
FUNDAMENTALS RATINGS
COLL vs DVAX: Fundamental Ratings
COLL
DVAX
OUTLOOK RATING
1..100
2113
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
69
Overvalued
PROFIT vs RISK RATING
1..100
4668
SMR RATING
1..100
4693
PRICE GROWTH RATING
1..100
5262
P/E GROWTH RATING
1..100
998
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COLL's Valuation (63) in the Pharmaceuticals Other industry is in the same range as DVAX (69) in the Biotechnology industry. This means that COLL’s stock grew similarly to DVAX’s over the last 12 months.

COLL's Profit vs Risk Rating (46) in the Pharmaceuticals Other industry is in the same range as DVAX (68) in the Biotechnology industry. This means that COLL’s stock grew similarly to DVAX’s over the last 12 months.

COLL's SMR Rating (46) in the Pharmaceuticals Other industry is somewhat better than the same rating for DVAX (93) in the Biotechnology industry. This means that COLL’s stock grew somewhat faster than DVAX’s over the last 12 months.

COLL's Price Growth Rating (52) in the Pharmaceuticals Other industry is in the same range as DVAX (62) in the Biotechnology industry. This means that COLL’s stock grew similarly to DVAX’s over the last 12 months.

COLL's P/E Growth Rating (9) in the Pharmaceuticals Other industry is significantly better than the same rating for DVAX (98) in the Biotechnology industry. This means that COLL’s stock grew significantly faster than DVAX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COLLDVAX
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 28 days ago
65%
Bearish Trend 18 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
COLL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IASTX23.92N/A
N/A
Macquarie Asset Strategy Fund Cl R6
BIAGX17.76N/A
N/A
Brown Advisory Growth Equity Inv
RSIFX28.15N/A
N/A
Victory RS Science and Technology A
PFGKX37.93N/A
N/A
Victory Pioneer Fundamental Growth R6
FNDMX13.34N/A
N/A
Fidelity Series Sust Non-US Dev Mrkt Fd

COLL and

Correlation & Price change

A.I.dvisor indicates that over the last year, COLL has been loosely correlated with AMPH. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if COLL jumps, then AMPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COLL
1D Price
Change %
COLL100%
+2.50%
AMPH - COLL
38%
Loosely correlated
-0.71%
ALKS - COLL
35%
Loosely correlated
+2.04%
SNDL - COLL
33%
Loosely correlated
+2.90%
AMRX - COLL
32%
Poorly correlated
+0.97%
SUPN - COLL
31%
Poorly correlated
+1.81%
More

DVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
+2.08%
ACET - DVAX
39%
Loosely correlated
+4.42%
SNDL - DVAX
35%
Loosely correlated
+2.90%
ESPR - DVAX
34%
Loosely correlated
+5.13%
SUPN - DVAX
34%
Loosely correlated
+1.81%
ALKS - DVAX
34%
Loosely correlated
+2.04%
More